Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Blood pressure lowering medication initiation and fracture risk: a SWAN pharmacoepidemiology study.

Solomon DH, Ruppert K, Kazlauskaite R, Finkelstein JS, Habel LA.

Arch Osteoporos. 2019 Jun 28;14(1):73. doi: 10.1007/s11657-019-0618-x.

PMID:
31254147
2.

Re: Cancer outcomes in DCIS patients without locoregional treatment.

Habel LA, Buist DSM.

J Natl Cancer Inst. 2019 Jun 14. pii: djz118. doi: 10.1093/jnci/djz118. [Epub ahead of print] No abstract available.

PMID:
31199466
3.

Gabapentin and Cancer Risk: Updated Findings from Kaiser Permanente Northern California.

Friedman GD, Achacoso N, Habel LA.

Perm J. 2019;23. pii: 18-040. doi: 10.7812/TPP/18-040.

4.

The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies.

Watts EL, Perez-Cornago A, Appleby PN, Albanes D, Ardanaz E, Black A, Bueno-de-Mesquita HB, Chan JM, Chen C, Chubb SAP, Cook MB, Deschasaux M, Donovan JL, English DR, Flicker L, Freedman ND, Galan P, Giles GG, Giovannucci EL, Gunter MJ, Habel LA, Häggström C, Haiman C, Hamdy FC, Hercberg S, Holly JM, Huang J, Huang WY, Johansson M, Kaaks R, Kubo T, Lane JA, Layne TM, Le Marchand L, Martin RM, Metter EJ, Mikami K, Milne RL, Morris HA, Mucci LA, Neal DE, Neuhouser ML, Oliver SE, Overvad K, Ozasa K, Pala V, Pernar CH, Pollak M, Rowlands MA, Schaefer CA, Schenk JM, Stattin P, Tamakoshi A, Thysell E, Touvier M, Trichopoulou A, Tsilidis KK, Van Den Eeden SK, Weinstein SJ, Wilkens L, Yeap BB, Key TJ, Allen NE, Travis RC.

Int J Cancer. 2019 Mar 15. doi: 10.1002/ijc.32276. [Epub ahead of print]

PMID:
30873591
5.

Reproductive Factors and Mammographic Density: Associations Among 24,840 Women and Comparison of Studies Using Digitized Film-Screen Mammography and Full-Field Digital Mammography.

Alexeeff SE, Odo NU, McBride R, McGuire V, Achacoso N, Rothstein JH, Lipson JA, Liang RY, Acton L, Yaffe MJ, Whittemore AS, Rubin DL, Sieh W, Habel LA.

Am J Epidemiol. 2019 Jun 1;188(6):1144-1154. doi: 10.1093/aje/kwz033.

PMID:
30865217
6.

Examining the role of access to care: Racial/ethnic differences in receipt of resection for early-stage non-small cell lung cancer among integrated system members and non-members.

Check DK, Albers KB, Uppal KM, Suga JM, Adams AS, Habel LA, Quesenberry CP Jr, Sakoda LC.

Lung Cancer. 2018 Nov;125:51-56. doi: 10.1016/j.lungcan.2018.09.006. Epub 2018 Sep 11.

PMID:
30429038
7.

Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer.

Banegas MP, Emerson MA, Adams AS, Achacoso NS, Chawla N, Alexeeff S, Habel LA.

J Cancer Surviv. 2018 Dec;12(6):794-802. doi: 10.1007/s11764-018-0716-6. Epub 2018 Oct 18.

PMID:
30338462
8.

Photosensitizing antihypertensive drug use and risk of cutaneous squamous cell carcinoma.

Su KA, Habel LA, Achacoso NS, Friedman GD, Asgari MM.

Br J Dermatol. 2018 Nov;179(5):1088-1094. doi: 10.1111/bjd.16713. Epub 2018 Aug 14.

PMID:
29723931
9.

A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus.

Bradley MC, Ferrara A, Achacoso N, Ehrlich SF, Quesenberry CP Jr, Habel LA.

Cancer Epidemiol Biomarkers Prev. 2018 May;27(5):525-530. doi: 10.1158/1055-9965.EPI-17-0424.

10.

Feasibility of analyzing DNA copy number variation in breast cancer tumor specimens from 1950 to 2010: how old is too old?

Krieger N, Nabavi S, Waterman PD, Achacoso NS, Acton L, Schnitt SJ, Habel LA.

Cancer Causes Control. 2018 Mar;29(3):305-314. doi: 10.1007/s10552-018-1006-3. Epub 2018 Feb 9.

11.

Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.

Watts EL, Appleby PN, Albanes D, Black A, Chan JM, Chen C, Cirillo PM, Cohn BA, Cook MB, Donovan JL, Ferrucci L, Garland CF, Giles GG, Goodman PJ, Habel LA, Haiman CA, Holly JMP, Hoover RN, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luostarinen T, MacInnis RJ, Mäenpää HO, Männistö S, Metter EJ, Milne RL, Nomura AMY, Oliver SE, Parsons JK, Peeters PH, Platz EA, Riboli E, Ricceri F, Rinaldi S, Rissanen H, Sawada N, Schaefer CA, Schenk JM, Stanczyk FZ, Stampfer M, Stattin P, Stenman UH, Tjønneland A, Trichopoulou A, Thompson IM, Tsugane S, Vatten L, Whittemore AS, Ziegler RG, Allen NE, Key TJ, Travis RC.

PLoS One. 2017 Dec 27;12(12):e0187741. doi: 10.1371/journal.pone.0187741. eCollection 2017.

12.

Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis.

Alford SH, Divine G, Chao C, Habel LA, Janakiraman N, Wang Y, Feigelson HS, Scholes D, Roblin D, Epstein MM, Engel L, Havstad S, Wells K, Yood MU, Fortuny J, Johnson CC; Cancer Research Network Lymphoma Study Group.

Cancer Causes Control. 2018 Jan;29(1):143-156. doi: 10.1007/s10552-017-0987-7. Epub 2017 Nov 30.

13.

Disparities in Prostate, Lung, Breast, and Colorectal Cancer Survival and Comorbidity Status among Urban American Indians and Alaskan Natives.

Emerson MA, Banegas MP, Chawla N, Achacoso N, Alexeeff SE, Adams AS, Habel LA.

Cancer Res. 2017 Dec 1;77(23):6770-6776. doi: 10.1158/0008-5472.CAN-17-0429. Epub 2017 Nov 29.

14.

Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery.

Punglia RS, Jiang W, Lipsitz SR, Hughes ME, Schnitt SJ, Hassett MJ, Nekhlyudov L, Achacoso N, Edge S, Javid SH, Niland JC, Theriault RL, Wong YN, Habel LA.

Breast Cancer Res Treat. 2018 Feb;167(3):751-759. doi: 10.1007/s10549-017-4553-5. Epub 2017 Oct 28.

PMID:
29079937
15.

Age at Menarche and Late Adolescent Adiposity Associated with Mammographic Density on Processed Digital Mammograms in 24,840 Women.

Alexeeff SE, Odo NU, Lipson JA, Achacoso N, Rothstein JH, Yaffe MJ, Liang RY, Acton L, McGuire V, Whittemore AS, Rubin DL, Sieh W, Habel LA.

Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1450-1458. doi: 10.1158/1055-9965.EPI-17-0264. Epub 2017 Jul 11.

16.

Research Letter: Anticholinergic Drugs and the Gallbladder -A Neglected Effect?

Friedman GD, Achacoso N, Habel LA.

Perm J. 2017;21:16-133. doi: 10.7812/TPP/16-133. No abstract available.

17.

Hydrochlorothiazide use is strongly associated with risk of lip cancer.

Pottegård A, Hallas J, Olesen M, Svendsen MT, Habel LA, Friedman GD, Friis S.

J Intern Med. 2017 Oct;282(4):322-331. doi: 10.1111/joim.12629. Epub 2017 Jun 6.

PMID:
28480532
18.

Statin use and risk of multiple myeloma: An analysis from the cancer research network.

Epstein MM, Divine G, Chao CR, Wells KE, Feigelson HS, Scholes D, Roblin D, Ulcickas Yood M, Engel LS, Taylor A, Fortuny J, Habel LA, Johnson CC.

Int J Cancer. 2017 Aug 1;141(3):480-487. doi: 10.1002/ijc.30745. Epub 2017 May 15.

19.

Feasibility of collecting tumor samples of breast cancer patients diagnosed up to 50 years ago in the Child Health and Development Studies.

Krigbaum NY, Rubin RA, Cirillo PM, Terry MB, Habel LA, Morris C, Cohn BA.

J Dev Orig Health Dis. 2017 Jun;8(3):331-336. doi: 10.1017/S204017441700006X. Epub 2017 Mar 6.

PMID:
28260556
20.

Effect of Race and Ethnicity on Antihypertensive Medication Utilization Among Women in the United States: Study of Women's Health Across the Nation (SWAN).

Jackson EA, Ruppert K, Derby CA, Lian Y, Neal-Perry G, Habel LA, Tepper PG, Harlow SD, Solomon DH.

J Am Heart Assoc. 2017 Feb 23;6(3). pii: e004758. doi: 10.1161/JAHA.116.004758.

21.

Oncologist and organizational factors associated with variation in breast cancer multigene testing.

Lieu TA, Ray GT, Prausnitz SR, Habel LA, Alexeeff S, Li Y, Ramsey SD, Phelps CE, Chawla N, C O'Neill S, Mandelblatt JS.

Breast Cancer Res Treat. 2017 May;163(1):167-176. doi: 10.1007/s10549-017-4158-z. Epub 2017 Feb 21.

22.

Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.

Hoffmann TJ, Passarelli MN, Graff RE, Emami NC, Sakoda LC, Jorgenson E, Habel LA, Shan J, Ranatunga DK, Quesenberry CP, Chao CR, Ghai NR, Aaronson D, Presti J, Nordström T, Wang Z, Berndt SI, Chanock SJ, Mosley JD, Klein RJ, Middha M, Lilja H, Melander O, Kvale MN, Kwok PY, Schaefer C, Risch N, Van Den Eeden SK, Witte JS.

Nat Commun. 2017 Jan 31;8:14248. doi: 10.1038/ncomms14248.

23.

The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening.

Chau SL, Alabaster A, Luikart K, Brenman LM, Habel LA.

J Prim Care Community Health. 2017 Apr;8(2):55-62. doi: 10.1177/2150131916674889. Epub 2016 Oct 31.

24.

Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma.

Pottegård A, Schmidt SA, Olesen AB, Achacoso N, Van Den Eeden SK, Hallas J, Sørensen HT, Friis S, Habel LA.

Br J Cancer. 2016 Sep 27;115(7):895-900. doi: 10.1038/bjc.2016.248. Epub 2016 Aug 16.

25.

Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early-Stage Breast Cancer: The LACE and Pathways Studies.

Jones LW, Kwan ML, Weltzien E, Chandarlapaty S, Sternfeld B, Sweeney C, Bernard PS, Castillo A, Habel LA, Kroenke CH, Langholz BM, Queensberry CP Jr, Dang C, Weigelt B, Kushi LH, Caan BJ.

Cancer Res. 2016 Sep 15;76(18):5415-22. doi: 10.1158/0008-5472.CAN-15-3307. Epub 2016 Aug 3.

26.

Statins and Reduced Risk of Liver Cancer: Evidence for Confounding.

Friedman GD, Achacoso N, Fireman B, Habel LA.

J Natl Cancer Inst. 2016 Jul 5;108(10). pii: djw109. doi: 10.1093/jnci/djw109. Print 2016 Oct.

27.

Identification of Associations Between Prescribed Medications and Cancer: A Nationwide Screening Study.

Pottegård A, Friis S, Christensen Rd, Habel LA, Gagne JJ, Hallas J.

EBioMedicine. 2016 May;7:73-9. doi: 10.1016/j.ebiom.2016.03.018. Epub 2016 Mar 14.

28.

Time for integrating clinical, lifestyle and molecular data to predict drug responses - Authors' reply.

Pottegård A, Friis S, Christensen Rd, Habel LA, Gagne JJ, Hallas J.

EBioMedicine. 2016 May;7:11. doi: 10.1016/j.ebiom.2016.03.019. Epub 2016 Mar 18. No abstract available.

29.

Breast cancer multigene testing trends and impact on chemotherapy use.

Ray GT, Mandelblatt J, Habel LA, Ramsey S, Kushi LH, Li Y, Lieu TA.

Am J Manag Care. 2016 May 1;22(5):e153-60.

30.

Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer.

Jones LW, Habel LA, Weltzien E, Castillo A, Gupta D, Kroenke CH, Kwan ML, Quesenberry CP Jr, Scott J, Sternfeld B, Yu A, Kushi LH, Caan BJ.

J Clin Oncol. 2016 Aug 10;34(23):2743-9. doi: 10.1200/JCO.2015.65.6603. Epub 2016 May 23.

31.

Case-control study of mammographic density and breast cancer risk using processed digital mammograms.

Habel LA, Lipson JA, Achacoso N, Rothstein JH, Yaffe MJ, Liang RY, Acton L, McGuire V, Whittemore AS, Rubin DL, Sieh W.

Breast Cancer Res. 2016 May 21;18(1):53. doi: 10.1186/s13058-016-0715-3.

32.

Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen.

Kwan ML, Shi JM, Habel LA, Song J, Chung JW, Avila CC, Schottinger JE, Cheetham TC, Fletcher SW, Haque R.

Breast Cancer Res Treat. 2016 Apr;156(2):379-89. doi: 10.1007/s10549-016-3763-6. Epub 2016 Mar 22.

PMID:
27002508
33.

A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk.

Travis RC, Appleby PN, Martin RM, Holly JMP, Albanes D, Black A, Bueno-de-Mesquita HBA, Chan JM, Chen C, Chirlaque MD, Cook MB, Deschasaux M, Donovan JL, Ferrucci L, Galan P, Giles GG, Giovannucci EL, Gunter MJ, Habel LA, Hamdy FC, Helzlsouer KJ, Hercberg S, Hoover RN, Janssen JAMJL, Kaaks R, Kubo T, Le Marchand L, Metter EJ, Mikami K, Morris JK, Neal DE, Neuhouser ML, Ozasa K, Palli D, Platz EA, Pollak M, Price AJ, Roobol MJ, Schaefer C, Schenk JM, Severi G, Stampfer MJ, Stattin P, Tamakoshi A, Tangen CM, Touvier M, Wald NJ, Weiss NS, Ziegler RG, Key TJ, Allen NE.

Cancer Res. 2016 Apr 15;76(8):2288-2300. doi: 10.1158/0008-5472.CAN-15-1551. Epub 2016 Feb 26.

34.

Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community.

Hassett MJ, Jiang W, Habel LA, Nekhlyudov L, Achacoso N, Acton L, Schnitt SJ, Schrag D, Punglia RS.

Breast Cancer Res Treat. 2016 Feb;155(3):541-9. doi: 10.1007/s10549-016-3692-4. Epub 2016 Feb 3.

35.

Analyzing historical trends in breast cancer biomarker expression: a feasibility study (1947-2009).

Krieger N, Habel LA, Waterman PD, Shabani M, Ellison-Loschmann L, Achacoso NS, Acton L, Schnitt SJ.

NPJ Breast Cancer. 2015;1. pii: 15016. Epub 2015 Oct 7.

36.

Pioglitazone Use and Risk of Bladder Cancer--Reply.

Ferrara A, Lewis JD, Habel LA.

JAMA. 2015 Dec 15;314(23):2568-9. doi: 10.1001/jama.2015.13915. No abstract available.

PMID:
26670978
37.

Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors.

Haque R, Shi J, Schottinger JE, Ahmed SA, Cheetham TC, Chung J, Avila C, Kleinman K, Habel LA, Fletcher SW, Kwan ML.

J Natl Cancer Inst. 2015 Dec 1;108(3). doi: 10.1093/jnci/djv337. Print 2016 Mar.

38.

Physical Activity and Risk of Male Breast Cancer.

Arem H, Brinton LA, Moore SC, Gapstur SM, Habel LA, Johnson K, Kolonel LN, McCormack VA, Michels KB, Sesso HD, Ursin G, Van Den Eeden SK, Weiderpass E, Cook MB, Matthews CE.

Cancer Epidemiol Biomarkers Prev. 2015 Dec;24(12):1898-901. doi: 10.1158/1055-9965.EPI-15-0588. Epub 2015 Sep 24.

39.

Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes.

Lewis JD, Habel LA, Quesenberry CP, Strom BL, Peng T, Hedderson MM, Ehrlich SF, Mamtani R, Bilker W, Vaughn DJ, Nessel L, Van Den Eeden SK, Ferrara A.

JAMA. 2015 Jul 21;314(3):265-77. doi: 10.1001/jama.2015.7996.

PMID:
26197187
40.

Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study.

Collins LC, Achacoso N, Haque R, Nekhlyudov L, Quesenberry CP Jr, Schnitt SJ, Habel LA, Fletcher SW.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S502-8. doi: 10.1245/s10434-015-4641-x. Epub 2015 Jun 10.

PMID:
26059650
41.

A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.

Hoffmann TJ, Van Den Eeden SK, Sakoda LC, Jorgenson E, Habel LA, Graff RE, Passarelli MN, Cario CL, Emami NC, Chao CR, Ghai NR, Shan J, Ranatunga DK, Quesenberry CP, Aaronson D, Presti J, Wang Z, Berndt SI, Chanock SJ, McDonnell SK, French AJ, Schaid DJ, Thibodeau SN, Li Q, Freedman ML, Penney KL, Mucci LA, Haiman CA, Henderson BE, Seminara D, Kvale MN, Kwok PY, Schaefer C, Risch N, Witte JS.

Cancer Discov. 2015 Aug;5(8):878-91. doi: 10.1158/2159-8290.CD-15-0315. Epub 2015 Jun 1.

42.

Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk.

Brinton LA, Key TJ, Kolonel LN, Michels KB, Sesso HD, Ursin G, Van Den Eeden SK, Wood SN, Falk RT, Parisi D, Guillemette C, Caron P, Turcotte V, Habel LA, Isaacs CJ, Riboli E, Weiderpass E, Cook MB.

J Clin Oncol. 2015 Jun 20;33(18):2041-50. doi: 10.1200/JCO.2014.59.1602. Epub 2015 May 11.

43.

Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival.

Kwan ML, Bernard PS, Kroenke CH, Factor RE, Habel LA, Weltzien EK, Castillo A, Gunderson EP, Maxfield KS, Stijleman IJ, Langholz BM, Quesenberry CP Jr, Kushi LH, Sweeney C, Caan BJ.

J Natl Cancer Inst. 2015 Apr 28;107(7). pii: djv087. doi: 10.1093/jnci/djv087. Print 2015 Jul.

44.

Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression.

Kwan ML, Kroenke CH, Sweeney C, Bernard PS, Weltzien EK, Castillo A, Factor RE, Maxfield KS, Stijleman IJ, Kushi LH, Quesenberry CP Jr, Habel LA, Caan BJ.

BMC Cancer. 2015 Apr 14;15:278. doi: 10.1186/s12885-015-1263-4.

45.

Racial/ethnic and socioeconomic differences in short-term breast cancer survival among women in an integrated health system.

Keegan TH, Kurian AW, Gali K, Tao L, Lichtensztajn DY, Hershman DL, Habel LA, Caan BJ, Gomez SL.

Am J Public Health. 2015 May;105(5):938-46. doi: 10.2105/AJPH.2014.302406. Epub 2015 Mar 19.

46.

A hybrid approach to identify subsequent breast cancer using pathology and automated health information data.

Haque R, Shi J, Schottinger JE, Ahmed SA, Chung J, Avila C, Lee VS, Cheetham TC, Habel LA, Fletcher SW, Kwan ML.

Med Care. 2015 Apr;53(4):380-5. doi: 10.1097/MLR.0000000000000327.

PMID:
25769058
47.

Metformin use and lung cancer risk in patients with diabetes.

Sakoda LC, Ferrara A, Achacoso NS, Peng T, Ehrlich SF, Quesenberry CP Jr, Habel LA.

Cancer Prev Res (Phila). 2015 Feb;8(2):174-9. doi: 10.1158/1940-6207.CAPR-14-0291.

48.

Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort.

Hoffmann TJ, Sakoda LC, Shen L, Jorgenson E, Habel LA, Liu J, Kvale MN, Asgari MM, Banda Y, Corley D, Kushi LH, Quesenberry CP Jr, Schaefer C, Van Den Eeden SK, Risch N, Witte JS.

PLoS Genet. 2015 Jan 28;11(1):e1004930. doi: 10.1371/journal.pgen.1004930. eCollection 2015 Jan. Erratum in: PLoS Genet. 2015 Apr;11(4):e1005114. PLoS Genet. 2015 Jun;11(6):e1005362.

49.

Treatment patterns for ductal carcinoma in situ from 2000-2010 across six integrated health plans.

Feigelson HS, Carroll NM, Weinmann S, Haque R, Yu CL, Butler MG, Waitzfelder B, Wrenn MG, Capra A, McGlynn EA, Habel LA.

Springerplus. 2015 Jan 17;4:24. doi: 10.1186/s40064-014-0776-7. eCollection 2015.

50.

Association between high-sensitivity C-reactive protein (hsCRP) and change in mammographic density over time in the SWAN mammographic density subcohort.

Makboon K, Gold EB, Harvey DJ, Butler LM, Habel LA.

Cancer Causes Control. 2015 Mar;26(3):431-42. doi: 10.1007/s10552-015-0522-7. Epub 2015 Jan 21.

Supplemental Content

Loading ...
Support Center